Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yoko Misawa"'
Autor:
Yuanjun Gu, Yasuhiko Tabata, Yoshiyuki Kawakami, Appakaalai N. Balamurugan, Hiroshi Hori, Natsuki Nagata, Akira Satake, Wanxing Cui, Meirigeng Qi, Yoko Misawa, Maki Toma, Masaaki Miyamoto, Masumi Nozawa, Kazutomo Inoue M.D., Ph.D.
Publikováno v:
Cell Transplantation, Vol 10 (2001)
The subcutaneous space is a potential site for clinical islet transplantation. Even though there are several advantages, poor blood supply at this site mainly causes failure of islet survival. In this study, angiogenesis was induced in advance at the
Externí odkaz:
https://doaj.org/article/233d2353825b4e2bb95a0c28acbde642
Publikováno v:
ChemInform. 33
Publikováno v:
The Journal of Antibiotics. 43:570-573
We describe the structure and antibacterial activity of the degradation products of 6-O-methylerythromycin A and its derivatives under acidic conditions.
Autor:
Yoko Misawa, Tetsuya Tanikawa, Masakazu Sato, Toshifumi Asaka, Masato Kashimura, Shigeo Morimoto, Atsushi Nishida, Keiko Suzuki, Kazuya Kameo
Publikováno v:
Journal of medicinal chemistry. 44(24)
Introduction of an acyl group to the 3-O-position of erythromycin A derivatives instead of L-cladinose led to a novel class of macrolide antibiotics that we named "acylides". The 3-O-nitrophenylacetyl derivative TEA0777 showed significantly potent ac
Publikováno v:
The Journal of antibiotics. 54(8)
The novel 6-O-methyl tricyclic ketolides TE-802 and its analogs were synthesized by two successive cyclization reactions, 11,12-cyclic carbamate formation by intramolecular Michael addition and 9,11-diazaheptene ring construction by intramolecular de
Autor:
Masato Kashimura, Yutaka Kawashima, Takeo Ono, Ikuo Moriguchi, Takatoshi Nagate, Yoko Misawa, Toshifumi Asaka, Yuki Yamada, Katsuo Hatayama, Sigeo Morimoto, Shuichi Hirono
Publikováno v:
Chemicalpharmaceutical bulletin. 42(5)
In order to develop new-generation macrolide antibiotics active against erythromycin (EM)-resistant strains, a series of 6-O-methyl EM 9-O-substituted oxime derivatives was synthesized and evaluated for antibacterial activity against EM-resistant (S.
Autor:
Takatoshi Nagate, Yoko Misawa, Yoshiaki Watanabe, Sadafumi Omura, Takashi Adachi, Shigeo Morimoto
Publikováno v:
The Journal of antibiotics. 43(5)
6-O-Methylerythromycin B has been synthesized from erythromycin B via regioselective methylation of the 6-hydroxyl group in 71 % overall yield. This compound shows in vitro antibacterial activity comparable to erythromycins A and B and exhibits super
Autor:
Kazuo Numata, Yoko Misawa, Kazuhiko Sugita, Sadafumi Omura, Junko Miyachi, Kenji Yamada, Takeo Ono, Takatoshi Nagate, Shigeo Morimoto
Publikováno v:
The Journal of antibiotics. 43(3)
The in vitro and in vivo antibacterial activities of 6-O-methylerythromycin A (TE-031, A-56268, or clarithromycin) and 6, 11-di-O-methylerythromycin A (TE-032) have been compared with those of erythromycin A (EM) and josamycin (JM). TE-031 and TE-032
Autor:
Wanxing Cui, Yoshiyuki Kawakami, Masumi Nozawa, Yoko Misawa, Akira Satake, Yuanjun Gu, Meirigeng Qi, Hiroshi Hori, Kazutomo Inoue, Yasuhiko Tabata, A. N. Balamurugan, Natsuki Nagata, Masaaki Miyamoto, Maki Toma
Publikováno v:
ResearcherID
Cell Transplantation, Vol 10 (2001)
Cell Transplantation, Vol 10 (2001)
The subcutaneous space is a potential site for clinical islet transplantation. Even though there are several advantages, poor blood supply at this site mainly causes failure of islet survival. In this study, angiogenesis was induced in advance at the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cf92c7d45f6849c9f713076a4b1535b
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000170544500019&KeyUID=WOS:000170544500019
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000170544500019&KeyUID=WOS:000170544500019